To characterize the pharmacokinetics and safety of dabrafenib following a single 100 mg oral
dose in subjects with moderate and severe hepatic impairment.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02873650
Ages eligible for Study
18 Years to 75 Years
Genders eligible for Study
Accepts Healthy Volunteers
All locations for NCT02873650
United States (4)
American Institute of Research
Los Angeles, California, United States, 900017
Omega Research Consultants LLC
DeBary, Florida, United States, 32713
Hassman Research Institute
Berlin, New Jersey, United States, 08009
Wake Research Associates Oncology
Raleigh, North Carolina, United States, 27612
View full eligibility
Tris trial is registered with FDA with number: NCT02873650. The sponsor of the trial is Novartis Pharmaceuticals and it is looking for 5 volunteers for the current phase.
Official trial title: A Phase I, Open Label, Multicenter, Single Dose Study to Evaluate the Pharmacokinetics of Dabrafenib in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.